Cargando…
Yokukansan improves behavioral and psychological symptoms of dementia by suppressing dopaminergic function
Although three drugs, risperidone, yokukansan, and fluvoxamine, have shown equal efficacy in treating behavioral and psychological symptoms of dementia (BPSD) in our previous study, their mechanisms of action are different from one another. Monoamines have attracted attention for their key roles in...
Autores principales: | Takeyoshi, Kenji, Kurita, Masatake, Nishino, Satoshi, Teranishi, Mika, Numata, Yukio, Sato, Tadahiro, Okubo, Yoshiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801203/ https://www.ncbi.nlm.nih.gov/pubmed/27042075 http://dx.doi.org/10.2147/NDT.S99032 |
Ejemplares similares
-
The Noradrenaline Metabolite MHPG Is a Candidate Biomarker from the Manic to the Remission State in Bipolar Disorder I: A Clinical Naturalistic Study
por: Kurita, Masatake, et al.
Publicado: (2014) -
The noradrenaline metabolite MHPG is a candidate biomarker between the depressive, remission, and manic states in bipolar disorder I: two long-term naturalistic case reports
por: Kurita, Masatake, et al.
Publicado: (2015) -
Plasma Brain-Derived Neurotrophic Factor Levels Predict the Clinical Outcome of Depression Treatment in a Naturalistic Study
por: Kurita, Masatake, et al.
Publicado: (2012) -
Need for medication to complement catecholamines in smoking cessation of hardcore smokers
por: Kawai, Atsuko, et al.
Publicado: (2017) -
Non-24-hour sleep–wake syndrome improved by low-dose valproic acid: a case report
por: Kurita, Masatake, et al.
Publicado: (2016)